290 related articles for article (PubMed ID: 31190863)
1. Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis.
Huang G; Zhang J; Wang X; Chen Y; Liu D; Guo S
Onco Targets Ther; 2019; 12():3609-3617. PubMed ID: 31190863
[No Abstract] [Full Text] [Related]
2. Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis.
Liu X; Huang G; Zhang J; Zhang L; Liang Z
PLoS One; 2020; 15(10):e0240321. PubMed ID: 33052949
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and prognostic value of S100A4 expression in non-small cell lung cancer: a meta-analysis.
Zhang J; Gu Y; Liu X; Rao X; Huang G; Ouyang Y
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32696952
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of NANOG expression in solid tumors: a meta-analysis.
Zhao L; Liu J; Chen S; Fang C; Zhang X; Luo Z
Onco Targets Ther; 2018; 11():5515-5526. PubMed ID: 30233213
[TBL] [Abstract][Full Text] [Related]
5. Prognostic and clinicopathological value of Nanog in hepatocellular carcinoma: A meta-analysis.
Liang C; Zhang K; Ge H; Li W; Li G; Wu J
Clin Chim Acta; 2018 Feb; 477():24-31. PubMed ID: 29198990
[TBL] [Abstract][Full Text] [Related]
6. The clinicopathological and prognostic value of Nanog in human gastrointestinal luminal cancer: A meta-analysis.
Liang C; Zhao T; Ge H; Xu Y; Ren S; Yue C; Li G; Wu J
Int J Surg; 2018 May; 53():193-200. PubMed ID: 29602014
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases.
Ye Z; Zhang X; Luo Y; Li S; Huang L; Li Z; Li P; Chen G
PLoS One; 2016; 11(9):e0163162. PubMed ID: 27657690
[TBL] [Abstract][Full Text] [Related]
8. The Prognostic Value of Nanog Overexpression in Lung Cancer: A Meta-Analysis.
Cheng W; Wang H; Yuan J; Cheng Z; Xing D; Zhang M
Biomed Res Int; 2018; 2018():3429261. PubMed ID: 30627549
[TBL] [Abstract][Full Text] [Related]
9. Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis.
Min SH; Zheng QQ
Medicine (Baltimore); 2021 Nov; 100(47):e27919. PubMed ID: 34964763
[TBL] [Abstract][Full Text] [Related]
10. Prognostic and clinicopathological value of osteopontin expression in non-small cell lung cancer: a meta-analysis and systematic review.
Song Y; Li H; Jiang Q; Wu L
Biomarkers; 2024 Mar; 29(2):105-113. PubMed ID: 38376506
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathologic impacts and prognostic significance of GLUT1 expression in patients with lung cancer: A meta-analysis.
Zhang B; Xie Z; Li B
Gene; 2019 Mar; 689():76-83. PubMed ID: 30552981
[TBL] [Abstract][Full Text] [Related]
12. The Clinical Significance and Prognostic Value of ALDH1 Expression in Non-small Cell Lung Cancer: A Systematic Review and Meta-analysis.
Li D; Cao Y; Luo CW; Zhang LP; Zou YB
Recent Pat Anticancer Drug Discov; 2023 Oct; ():. PubMed ID: 37818578
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic Features and Prognostic Implications of Golgi Phosphoprotein 3 in Non-small Cell Lung Cancer: A Meta-analysis.
Shi W; Feng W; Wang J; Zhai C; Zhang Q; Wang Q; Song Y; Yan X; Chai L; Liu P; Chen Y; Li C; Li M
J Cancer; 2019; 10(23):5754-5763. PubMed ID: 31737112
[No Abstract] [Full Text] [Related]
14. Clinicopathological and prognostic significance of Oct-4 expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Li SJ; Huang J; Zhou XD; Zhang WB; Lai YT; Che GW
J Thorac Dis; 2016 Jul; 8(7):1587-600. PubMed ID: 27499947
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological and prognostic significance of Nestin expression in patients with non-small cell lung cancer: a systematic review and meta-analysis.
Li S; Lai Y; Fan J; Shen C; Che G
Clin Exp Med; 2017 May; 17(2):161-174. PubMed ID: 27099933
[TBL] [Abstract][Full Text] [Related]
16. Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation.
Li Z; Huang Y; Zhou R; Li Z; Yan Q
Medicine (Baltimore); 2023 Jul; 102(29):e34312. PubMed ID: 37478236
[TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological significance of miR-638 in cancer patients: A meta-analysis.
Hu L; Huang M; Yuan Q; Kong F
Medicine (Baltimore); 2021 Apr; 100(15):e25441. PubMed ID: 33847647
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological and prognostic value of LINC01296 in cancers: a meta-analysis.
Feng W; Zhai C; Shi W; Zhang Q; Yan X; Wang J; Wang Q; Li M
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):3315-3321. PubMed ID: 31385542
[No Abstract] [Full Text] [Related]
19. Clinicopathological and prognostic significance of programmed cell death ligand1 (PD-L1) expression in patients with non-small cell lung cancer: a meta-analysis.
Pan ZK; Ye F; Wu X; An HX; Wu JX
J Thorac Dis; 2015 Mar; 7(3):462-70. PubMed ID: 25922726
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of B7-H3 correlates with aggressive clinicopathological characteristics in non-small cell lung cancer.
Wu S; Zhao X; Wu S; Du R; Zhu Q; Fang H; Zhang X; Zhang C; Zheng W; Yang J; Feng H
Oncotarget; 2016 Dec; 7(49):81750-81756. PubMed ID: 27835582
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
